EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 64 filers reported holding EIDOS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $17,911,000 | +155.7% | 136,117 | -1.8% | 0.00% | +50.0% |
Q3 2020 | $7,006,000 | +8.1% | 138,660 | +1.9% | 0.00% | 0.0% |
Q2 2020 | $6,484,000 | -5.9% | 136,020 | -3.3% | 0.00% | 0.0% |
Q1 2020 | $6,892,000 | -14.2% | 140,685 | +0.5% | 0.00% | 0.0% |
Q4 2019 | $8,031,000 | +55.5% | 139,935 | -2.5% | 0.00% | +100.0% |
Q3 2019 | $5,163,000 | -9.8% | 143,553 | -22.0% | 0.00% | 0.0% |
Q2 2019 | $5,723,000 | +34.5% | 184,115 | +1.5% | 0.00% | 0.0% |
Q1 2019 | $4,255,000 | +227.1% | 181,468 | +91.8% | 0.00% | – |
Q4 2018 | $1,301,000 | +44.9% | 94,601 | +5.1% | 0.00% | – |
Q3 2018 | $898,000 | +219.6% | 90,007 | +551.0% | 0.00% | – |
Q2 2018 | $281,000 | – | 13,825 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|